Bridge Biotherapeutics, Inc. (KOSDAQ: 288330)

Bridge Biotherapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	182,554	73,111	230,799	279,845	279,086	317,282
Market Cap Growth	-57.47%	-68.32%	-17.53%	0.27%	-12.04%	-
Enterprise Value	179,228	50,708	172,628	231,285	216,852	319,939
Last Close Price	3985.00	2386.14	8425.95	10314.52	10568.76	13897.97
PE Ratio	-	-1.39	-4.81	-9.20	-12.56	121.59
PS Ratio	-332083333.33	731.11	76.33	145.44	44.02	5.44
PB Ratio	9.88	3.71	4.45	6.50	4.71	4.23
P/FCF Ratio	-1.64	-2.28	-5.68	-13.14	-21.28	-38.74
P/OCF Ratio	-1.65	-2.30	-5.74	-13.25	-21.41	-41.22
EV/Sales Ratio	-105705175.01	507.08	57.09	120.20	34.20	5.49
EV/EBITDA Ratio	-1.24	-1.30	-4.07	-8.89	-11.28	299.40
EV/EBIT Ratio	-1.18	-1.26	-3.97	-8.76	-11.08	518.38
EV/FCF Ratio	-6.52	-1.58	-4.25	-10.86	-16.53	-39.06
Debt / Equity Ratio	0.25	0.18	0.06	0.01	0.01	0.00
Debt / EBITDA Ratio	-	-	-	-	-	0.15
Debt / FCF Ratio	-0.11	-0.11	-0.07	-0.01	-0.03	-0.02
Asset Turnover	-	0.00	0.06	0.03	0.09	1.28
Quick Ratio	1.51	2.01	6.97	12.23	56.55	15.34
Current Ratio	1.57	2.09	7.33	12.49	57.14	16.72
Return on Equity (ROE)	-143.32%	-118.61%	-87.87%	-51.39%	-28.65%	6.52%
Return on Assets (ROA)	-58.54%	-53.58%	-50.30%	-29.95%	-17.08%	0.84%
Return on Capital (ROIC)	-67.36%	-64.55%	-55.40%	-32.06%	-18.15%	1.50%
Earnings Yield	-31.21%	-57.89%	-18.07%	-9.39%	-6.89%	0.42%
FCF Yield	-15.06%	-43.90%	-17.60%	-7.61%	-4.70%	-2.58%
Buyback Yield / Dilution	-21.53%	-3.58%	-1.56%	-2.53%	-96.53%	-64.86%
Total Shareholder Return	-21.53%	-3.58%	-1.56%	-2.53%	-96.53%	-64.86%

Source: S&P Capital IQ. Standard template. Financial Sources.